Search Results

Search criteria:

Author:

Maurer, H.H.

You may also wish to search for items by Maurer, H. and Maurer.

33 matching references were found.

Maurer, H.H., Identification and differentiation of barbiturates, other sedative-hypnotics and their metabolites in urine integrated in a general screening procedure using computerized gas chromatography-mass spectrometry, J. Chromatogr., 1990, 530, 307-326, https://doi.org/10.1016/S0378-4347(00)82334-8 . [all data]

Maurer, H.H.; Arlt, J.W., Screening procedure for detection of dihydropyridine calcium channel blocker metabolites in urine as part of a systematic toxicological analysis procedure for acidic compounds by gas chromatography-mass spectrometry after extractive methylation, J. Anal. Toxicol., 1999, 23, 2, 73-80, https://doi.org/10.1093/jat/23.2.73 . [all data]

Maurer, H.H.; Bickeboeller-Friedrich, J., Screening procedure for detection of antidepressants of the selective serotonin reuptake inhibitor type and their metabolites in urine as part of a modified systematic toxicological analysis procedure using gas chromatography-mass spectrometry, J. Anal. Toxicol., 2000, 24, 5, 340-347, https://doi.org/10.1093/jat/24.5.340 . [all data]

Maurer, H.H.; Tauvel, F.X.; Kraemer, T., Screening procedure for detection of non-steroidal anti-inflammatory drugs and their metabolites in urine as part of a systematic toxicological analysis procedure for acidic drugs and poisons by gas chromatography-mass spectrometry after extractive methylation, J. Anal. Toxicol., 2001, 25, 237-244. [all data]

Bickeboeller-Friedrich, J.; Maurer, H.H., Screening for detection of new antidepressants, neuroleptics, hypnotics, and their metabolites in urine by GC-MS developed using rat liver microsomes, Ther. Drug Monit., 2001, 23, 1, 61-70, https://doi.org/10.1097/00007691-200102000-00012 . [all data]

Maurer, H.H., Role of gas chromatography-mass spectrometry with negative ion chemical ionization in clinical and forensic toxicology, doping control, and biomonitoring, Ther. Drug Monit., 2002, 24, 2, 247-254, https://doi.org/10.1097/00007691-200204000-00007 . [all data]

Maurer, H.H., Identification of antiarrhythmic drugs and their metabolites in urine, Arch. Toxicol., 1990, 64, 3, 218-230, https://doi.org/10.1007/BF02010728 . [all data]

Maurer, H.H., Detection of anticonvulsants and their metabolites in urine within a general unknown analysis procedure using computerized gas chromatography-mass spectrometry, Arch. Toxicol., 1990, 64, 7, 554-561, https://doi.org/10.1007/BF01971834 . [all data]

Maurer, H.H., Screening procedures for simultaneous detection of several drug classes used for high throughput toxicological analyses and doping control. A review, Comb. Chem. High Throughput Screening, 2000, 3, 6, 467-480, https://doi.org/10.2174/1386207003331355 . [all data]

Staack, R.F.; Fehn, J.; Maurer, H.H., New designer drug p-methoxymethamphetamine: studies on its metabolism and toxicological detection in urine using gas chromatography-mass spectrometry, J. Chromatogr. B, 2003, 789, 1, 27-41, https://doi.org/10.1016/S1570-0232(02)01018-8 . [all data]

Paul, L.D.; Maurer, H.H., Studies on the metabolism and toxicological detection of the Eschscholtzia californica alkaloids californine and protopine in urine using gas chromatography-mass spectrometry, J. Chromatogr. B, 2003, 789, 1, 43-57, https://doi.org/10.1016/S1570-0232(03)00124-7 . [all data]

Springer, D.; Peters, F.T.; Fritschi, G.; Maurer, H.H., New designer drug 4'-methyl-α-pyrrolidinohexanophenone: studies on its metabolism and toxicological detection in urine using gas chromatography-mass spectrometry, J. Chromatogr. B, 2003, 789, 1, 79-91, https://doi.org/10.1016/S1570-0232(03)00043-6 . [all data]

Staack, R.F.; Fritschi, G.; Maurer, H.H., Studies on the metabolism and toxicological detection of the new designer drug N-benzylpiperazine in urine using gas chromatography-mass spectrometry, J. Chromatogr. B, 2002, 773, 1, 35-46, https://doi.org/10.1016/S1570-0232(01)00619-5 . [all data]

Ensslin, H.K.; Kovar, K.-A.; Maurer, H.H., Toxicological detection of the designer drug 3,4-methylenedioxyethylamphetamine (MDE, Eve) and its metabolites in urine by gas chromatography-mass spectrometry and fluorescence polarization immunoassay, J. Chromatogr. B, 1996, 683, 2, 189-197, https://doi.org/10.1016/0378-4347(96)00129-6 . [all data]

Maurer, H.H.; Kraemer, T.; Ledvinka, O.; Schmitt, C.J.; Weber, A.A., Gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-mass spectrometry (LC-MS) in toxicological analysis. Studies on the detection of clobenzorex and its metabolites within a systematic toxicological analysis procedure by GC-MS and by immunoassay and studies on the detection of α- and β-amanitin in urine by atmospheric pressure ionization electrospray LC-MS, J. Chromatogr. B, 1997, 689, 81-89. [all data]

Kraemer, T.; Theis, G.A.; Weber, A.A.; Maurer, H.H., Studies on the metabolism and toxicological detection of the amphetamine-like anorectic fenproporex in human urine by gas chromatography-mass spectrometry and fluorescence polarization immunoassay, J. Chromatogr. B, 2000, 738, 1, 107-118, https://doi.org/10.1016/S0378-4347(99)00497-1 . [all data]

Springer, D.; Peters, F.T.; Fritschi, G.; Maurer, H.H., Studies on the metabolism and toxicological detection of the new designer drug 4'-methyl-α-pyrrolidinopropiophenone in urine using gas chromatography-mass spectrometry, J. Chromatogr. B, 2002, 773, 1, 25-33, https://doi.org/10.1016/S1570-0232(01)00578-5 . [all data]

Springer, D.; Fritschi, G.; Maurer, H.H., Metabolism and toxicological detection of the new designer drug 3',4'-methylenedioxy-α-pyrrolidinopropiophenone studied in urine using gas chromatography-mass spectrometry, J. Chromatogr. B, 2003, 793, 2, 377-388, https://doi.org/10.1016/S1570-0232(03)00350-7 . [all data]

Springer, D.; Fritschi, G.; Maurer, H.H., Metabolism and toxicological detection of the new designer drug 4'-methoxy-α-pyrrolidinopropiophenone studied in rat urine using gas chromatography-mass spectrometry, J. Chromatogr. B, 2003, 793, 2, 331-342, https://doi.org/10.1016/S1570-0232(03)00334-9 . [all data]

Paul, L.D.; Springer, D.; Staack, R.F.; Kraemer, T.; Maurer, H.H., Cytochrome P450 isoenzymes involved in rat liver microsomal metabolism of californine and protopine, Eur. J. Pharmacol., 2004, 485, 1-3, 69-79, https://doi.org/10.1016/j.ejphar.2003.11.051 . [all data]

Staack, R.F.; Maurer, H.H., Toxicological detection of the new designer drug 1-(4-methoxyphenyl)piperazine and its metabolites in urine and differentiation from an intake of structurally related medicaments using gas chromatography-mass spectrometry, J. Chromatogr. B, 2003, 798, 2, 333-342, https://doi.org/10.1016/j.jchromb.2003.10.004 . [all data]

Staack, R.F.; Maurer, H.H., Studies on the metabolism and the toxicological analysis of the nootropic drug fipexide in rat urine using gas chromatography-mass spectrometry, J. Chromatogr. B, 2004, 804, 2, 337-343, https://doi.org/10.1016/j.jchromb.2004.01.035 . [all data]

Springer, D.; Fritschi, G.; Maurer, H.H., Metabolism of the new designer drug α-pyrrolidinopropiophenone (PPP) and the toxicological detection of PPP and 4'-methyl-α-pyrrolidinopropiophenone (MPPP) studied in rat urine using gas chromatography-mass spectrometry, J. Chromatogr. B, 2003, 796, 2, 253-266, https://doi.org/10.1016/j.jchromb.2003.07.008 . [all data]

Staack, R.F.; Maurer, H.H., New designer drug 1-(3,4-methylenedioxybenzyl) piperazine (MDBP): studies on its metabolism and toxicological detection in rat urine using gas chromatography/mass spectrometry, J. Mass Spectrom., 2004, 39, 3, 255-261, https://doi.org/10.1002/jms.556 . [all data]

Theobald, D.S.; Fehn, S.; Maurer, H.H., New designer drug, 2,5-dimethoxy-4-propylthio-β-phenethylamine (2C-T-7): studies on its metabolism and toxicological detection in rat urine using gas chromatography/mass spectrometry, J. Mass Spectrom., 2005, 40, 1, 105-116, https://doi.org/10.1002/jms.784 . [all data]

Staack, R.F.; Fritschi, G.; Maurer, H.H., New designer drug 1-(3-trifluoromethylphenyl) piperazine (TFMPP): gas chromatography/mass spectrometry and liquid chromatography/mass spectrometry studies on its phase I and II metabolism and on its toxicological detection in rat urine, J. Mass Spectrom., 2003, 38, 9, 971-981, https://doi.org/10.1002/jms.513 . [all data]

Ewald, A.H.; Peters, F.T.; Weise, M.; Maurer, H.H., Studies on the metabolism and toxicological detection of the designer drug 4-methylthioamphetamine (4-MTA) in human urine using gas chromatography?mass spectrometry, J. Chromatogr. B, 2005, 824, 1-2, 123-131, https://doi.org/10.1016/j.jchromb.2005.07.007 . [all data]

Peters, F.T.; Meyer, M.R.; Fritschi, G.; Maurer, H.H., Studies on the metabolism and toxicological detection of the new designer drug 4'-methyl-α-pyrrolidinobutyrophenone (MPBP) in rat urine using gas chromatography-mass spectrometry, J. Chromatogr. B, 2005, 824, 1-2, 81-91, https://doi.org/10.1016/j.jchromb.2005.07.003 . [all data]

Theobald, D.S.; Maurer, H.H., Studies on the metabolism and toxicological detection of the designer drug 4-ethyl-2,5-dimethoxy-β-phenethylamine (2C-E) in rat urine using gas chromatographic-mass spectrometric techniques, J. Chromatogr. B, 2006, 842, 2, 76-90, https://doi.org/10.1016/j.jchromb.2006.03.001 . [all data]

Theobald, D.S.; Maurer, H.H., Studies on the metabolism and toxicological detection of the designer drug 2,5-dimethoxy-4-methyl-β-phenethylamine (2C-D) in rat urine using gas chromatographic/mass spectrometric techniques, J. Mass Spectrom., 2006, 41, 11, 1509-1519, https://doi.org/10.1002/jms.1128 . [all data]

Theobald, D.S.; Pütz, M.; Schneider, E.; Maurer, H.H., New designer drug 4-iodo-2,5-dimethoxy-β-phenethylamine (2C-I): Studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric and capillary electrophoretic/mass spectrometric techniques, J. Mass Spectrom., 2006, 41, 7, 872-886, https://doi.org/10.1002/jms.1045 . [all data]

Maurer, H.H.; Kraemer, T.; Arlt, J.W., Screening for the detection of angiotensin-converting enzyme inhybitors, their metabolites, and AT II receptor antagonists, Therapeutical Drug Monitoring, 1998, 20, 6, 706-713, https://doi.org/10.1097/00007691-199812000-00022 . [all data]

Meyer, M.R.; Willheim, J.; Peters, F.T.; Maurer, H.H., Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography - mass pectrometry, Anal. Bioanal. Chem., 2010, 397, 3, 1225-1233, https://doi.org/10.1007/s00216-010-3636-5 . [all data]